Comparing MTA Pulpotomy to Root Canal Treatment in Management of Permanent Molars With Irreversible Pulpitis in Children

Launched by AIN SHAMS UNIVERSITY · Jun 28, 2024

Keywords

ClinConnect Summary

This clinical trial is looking at two different treatments for children aged 10 to 14 who have a painful dental condition called irreversible pulpitis, which affects their first permanent molars. Specifically, the study is comparing a treatment called MTA pulpotomy, which is a less invasive procedure that removes the damaged tissue and preserves healthy tissue, to the more traditional root canal treatment. The goal is to see which treatment results in less pain and better healing for the tooth.

To participate in this trial, children must be generally healthy and show signs of irreversible pulpitis in one of their first permanent molars. However, children with certain conditions, such as teeth with immature roots or other serious dental issues, will not be eligible. If your child is selected, they will receive one of the two treatments and will be monitored afterward to see how well they recover. This trial is not yet recruiting participants, but it aims to find a more effective and comfortable treatment option for children with this common dental problem.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Healthy male and female children, aged 10 to 14 years
• • Signs and symptoms of irreversible pulpitis in carious first permanent molar.
• Exclusion Criteria:
• • Molars with immature roots
• • Non-restorable molars, with abnormal mobility or increased probing pocket depth (normal range = 1-3 mm)
• • Any indication of pulpal necrosis, such as sinus tract or swelling or no bleeding from orifices after access opening.
• • Any signs of periapical or furcal rarefaction.